Loading...
•
Sep 30, 2020
DaVita Q3 2020 Earnings Report
DaVita's Q3 2020 financial performance was strong, with a continued focus on patient care and safety amidst the challenges of COVID-19.
Key Takeaways
DaVita Inc. reported consolidated revenues of $2.924 billion and an operating income of $438 million for the third quarter ended September 30, 2020. Diluted earnings per share from continuing operations were $1.28, and adjusted diluted earnings per share were $1.80. The company also generated $483 million in operating cash flow and $287 million in free cash flow.
Consolidated revenues reached $2.924 billion.
Operating income was $438 million, representing a 15.0% operating margin.
Diluted earnings per share from continuing operations stood at $1.28, with adjusted diluted earnings per share at $1.80.
Operating cash flow from continuing operations was $483 million, and free cash flow from continuing operations was $287 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
DaVita provided its 2020 guidance, with revenue expected to be between $11.5 billion and $11.6 billion. Adjusted operating income margin is expected to be between 15.3% and 15.6%. The effective income tax rate on adjusted income from continuing operations attributable to DaVita Inc. is expected to be between 28.0% and 29.5%. Adjusted diluted net income from continuing operations per share attributable to DaVita Inc. is expected to be between $7.35 and $7.60. Capital expenditures from continuing operations are expected to be between $650 million and $690 million. Free cash flow from continuing operations is expected to be between $1.1 billion and $1.25 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...